 RBC Capital Markets expects Bausch Health Companies Inc NYSE: BHC Q1 FY22 revenue of 2.02 billion previous 2.04 billion; consensus 2.05 billion and adjusted EBITDA of 799 million previous 816 million; consensus 819 million. The forecasts suggest a 0.4 yy. 